loader image
Friday, February 20, 2026
90.5 F
McAllen
- Advertisement -

Lowering Prescription Drug Costs for Texans

Translate to Spanish or other 102 languages!

U.S. Senator John Cornyn (R-TX) discussed his bipartisan Affordable Prescriptions for Patients Act, which passed unanimously out of the Senate Judiciary Committee last Congress and would help lower drug prices. Image Source: United States Senate, Public domain, via Wikimedia Commons for illustration purposes
U.S. Senator John Cornyn (R-TX) discussed his bipartisan Affordable Prescriptions for Patients Act, which passed unanimously out of the Senate Judiciary Committee last Congress and would help lower drug prices. Image Source: United States Senate, Public domain, via Wikimedia Commons for illustration purposes

Mega Doctor News

- Advertisement -

WASHINGTON, DC – Today on the floor, U.S. Senator John Cornyn (R-TX) discussed his bipartisan Affordable Prescriptions for Patients Act, which passed unanimously out of the Senate Judiciary Committee last Congress and would help lower drug prices by preventing bad actors’ anti-competitive use of patents to block generic and biosimilar competition from coming to market. Excerpts of Sen. Cornyn’s remarks are below, and video can be found here

“The list price for Humira is more than $80,000 per year per patient. That’s higher than the median household income in Texas.”

“Humira is one of the most egregious examples of patent abuse, but it’s far from the only one.”

- Advertisement -

“Earlier this week Senator Blumenthal, the Senator from Connecticut, and I reintroduced a bill called the Affordable Prescriptions for Patients Act to put an end to this anti-competitive practice that keeps drug prices artificially high.”

“There are two practices in particular that this bill will address. One is called patent thicketing, which involves building layers upon layers of patents to prevent competitors from ever hitting the market. That’s what AbbVie did with Humira.”

“The other anticompetitive behavior this bill will address is something called product hopping, which occurs when a company develops a reformulation of a product that’s about to lose exclusivity, and then pulls the original product off the market. This is done not because the new formula is more effective, but because it prevents generic competitors.”

“The Affordable Prescriptions for Patients Act puts an end to this practice by expressly prohibiting manufacturers from engaging in product hopping. It also facilitates market entry for generics and biosimilars, which lead to more options and lower prices for patients.”

- Advertisement -

“Patients in Texas and across the country are experiencing sticker shock at the pharmacy counter like never before.”

“There’s a bipartisan desire to stop the anti-competitive behaviors that I described here today that are costing patients and taxpayers a fortune, and I hope we can make progress this Congress and finally put a stop to some of the gamesmanship.”

Senator John Cornyn, a Republican from Texas, is a member of the Senate Finance, Intelligence, and Judiciary Committees.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STC’s Valerio Named Key Contributor to Texas Health Care Workforce Reforms

Mega Doctor News By Selene Rodriguez South Texas College Regional Health Care Liaison...

The Hidden Sugar Crisis Threatening Our Kids’ Health

A growing body of research reveals that excessive sugar consumption in childhood is linked to a frightening list of long-term health problems, including an increased risk for heart disease, as well as obesity and type 2 diabetes. Consistent, high sugar intake can lead to serious health consequences such as these conditions.

Community Invited to DHR Health’s 16th Annual Free Health Fair, Feb. 21st 

In an effort to increase access to health services and resources, DHR Health will host its 16th annual Community Health Fair on Saturday, February 21, 2026, at the Edinburg Conference Center at Renaissance, located at 118 Paseo del Prado in Edinburg. This free community event will take place from 8:00 a.m. to noon and is open to the public.

Can AI Help Predict Outcomes in Ovarian Cancer?

 An international team of researchers has received $2 million in support to understand how artificial intelligence can improve prediction of ovarian cancer survival and treatment response
- Advertisement -
×